Comprehensive two-dimensional gas chromatography (GCXC) has been performed to identify the origins of a mysterious oil sheen in the Gulf of Mexico, first reported in September 2012. The results have been published in the journal Environmental Science and Technology1 by researchers from the University of California (California, USA) and the Wood Hole Oceanographic Institute (WHOI) (Massachusetts, USA).
Comprehensive two-dimensional gas chromatography (GCXGC) has been performed to identify the origins of a mysterious oil sheen in the Gulf of Mexico, first reported in September 2012. The results have been published in the journal Environmental Science andTechnology1 by researchers from the University of California (California, USA) and the Wood Hole Oceanographic Institute (WHOI) (Massachusetts, USA).
The sheen was reported close to the Deepwater Horizon disaster site in the Gulf of Mexico. An explosion on the Deepwater Horizon oil platform during the drilling of the Macondo oil well in April 2010 resulted in the release of nearly 5 million barrels of oil into the Gulf of Mexico.1
Report of the sheen initially sparked concerns that the capped well had begun to leak; however, by using a patented methodutilizing comprehensive GCXGC, the team was able to prove that this was not the case. David L. Valentine of the Universityof California (California, USA) told The Column that the work shows that the sheen is not originating from the well itself and,although welcome news, it serves as a warning that the oil from the disaster still persists.
The team collected 14 sheen samples from the surface of the gulf for fingerprinting with GCXGC, which were then compared against samples collected at the time of the disaster and in the years following.
Valentine told The Column that the sampling was not as easy as might be assumed. He commented: “The site is far from landand it was rough going to collect samples offshore in the winter — we almost didn’t make it there on one of our trips. And theforensic sleuthing we needed to do was also quite a challenge — the chemistry was not simple.”
Christoph Aeppli (WHOI) told The Column: “We were able to detect small amounts of olefins, man-made chemicals used indeep sea drilling in the samples, in oil sheen samples.” He added: “It is generally challenging to detect single target compoundsin the thousands of oil hydrocarbons using traditional GC analysis. We therefore used comprehensive two-dimensional GC(GCXGC) that allowed us to identify and even quantify olefins amounting to less than 0.1% of the total hydrocarbons for mostsamples.”
The presence of olefins in the samples meant that the team could rule out the Macondo well and other natural seeps. The authors concluded that the oil sheen must originate from the wreckage of the oil platform. At the time of the explosion the platform contained barrels of oil and mud mixtures from drilling the well that the authors hypothesized were being released into the sea by the corrosion of the barrels by the seawater. According to Aeppli, this is good news because this oil is a finite volume.
The study demonstrated the forensic application of drilling mud olefin analysis in the identification of oil sheens. Aeppli told TheColumn that the method was in fact first developed for analysing oil extracted from a newly drilled well, as olefin contaminationis a common problem. A method first developed and patented with the oil industry in mind has subsequently been proven usefulin environmental monitoring.
Reference
1. C. Aeppli, C. Reddy, R.K. Nelson, M.Y. Kellermann, and D.L. Valentine, Environmental Science and Technology DOI: 10.1021/es4024139 (2013).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.